EPLAW PATENT BLOG

UK – Regeneron v. Kymab and Novo Nordisk

Posted: June 4th, 2018

Regeneron Pharmaceuticals, Inc v Kymab Limited and Novo Nordisk A/S, UK Court of Appeal, 23 May 2018, [2018] EWCA 1186 (Civ) This is a judgment from the Court of Appeal on the appropriate form of order to be made following its finding that two of Regeneron’s patents are valid and infringed. At first instance, Henry […]

READ MORE